Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Caffeine is widely used to improve neonatal health in animals with low vitality. Due to its pharmacokinetics and pharmacodynamics, caffeine stimulates the cardiorespiratory system by antagonism of adenosine receptors and alteration in Ca ion channel activity. Moreover, the availability of intracellular Ca also has positive inotropic effects by increasing heart contractibility and by having a possible positive effect on neonate vitality. Nonetheless, since neonatal enzymatic and tissular systems are immature at birth, there is a controversy about whether caffeine is an effective therapy for newborns. This review aims to analyze the basic concepts of caffeine in neonatal animal models (rat and mouse pups, goat kids, lambs, and piglets), and it will discuss the neuroprotective effect and its physiological actions in reducing apnea in newborns.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252037PMC
http://dx.doi.org/10.3390/ani13111769DOI Listing

Publication Analysis

Top Keywords

animal models
8
caffeine
5
cardiorespiratory neuroprotective
4
neuroprotective effects
4
effects caffeine
4
caffeine neonate
4
neonate animal
4
models caffeine
4
caffeine improve
4
improve neonatal
4

Similar Publications

The emergence of organoid models has significantly bridged the gap between traditional cell cultures/animal models and authentic human disease states, particularly for genetic disorders, where their inherent genetic fidelity enables more biologically relevant research directions and enhances translational validity. This review systematically analyzes established organoid models of genetic diseases across organs (e.g.

View Article and Find Full Text PDF

Harmonizing mouse anatomy terminology: a common language?

Mamm Genome

September 2025

Department of Animal Health and Anatomy, Center for Animal Biotechnology and Gene Therapy, Universitat Autònoma de Barcelona, Travessera Dels Turons, 08193, Cerdanyola del Vallès, Barcelona, Spain.

The mouse remains the principal animal model for investigating human diseases due, among other reasons, to its anatomical similarities to humans. Despite its widespread use, the assumption that mouse anatomy is a fully established field with standardized and universally accepted terminology is misleading. Many phenotypic anatomical annotations do not refer to the authority or origin of the terminology used, while others inappropriately adopt outdated or human-centric nomenclature.

View Article and Find Full Text PDF

Automated Facial Aesthetics Evaluation: Performance of the Beauty Scanner-Face Analyzer in Measuring Symmetry and Proportions.

Aesthetic Plast Surg

September 2025

Department of Plastic and Cosmetic Surgery, Tongji Hospital, School of Medicine, Tongji University, No.389 Xincun Road, Shanghai, 200092, China.

Background: The integration of digital tools in aesthetic medicine has enhanced the precision of facial feature analysis. Using concepts like the Golden Ratio, these technologies enable more objective assessments of facial proportions and symmetry. The beauty scanner-face analyzer (BS-FA) app offers a digital approach to evaluate geometric proportions and facial alignment, providing valuable data for preoperative planning in plastic surgery and aesthetic treatments.

View Article and Find Full Text PDF

Human gastroids to model regional patterning in early stomach development.

Nature

September 2025

Institute of Biomechanics and Medical Engineering, Applied Mechanics Laboratory, Department of Engineering Mechanics, Tsinghua University, Beijing, China.

The human stomach features distinct, regionalized functionalities along the anterior-posterior axis. Historically, studies on stomach patterning have used animal models to identify the underlying principles. Recently, human pluripotent stem (hPS)-cell-based gastric organoids for modelling domain-specific development of the fundic and antral epithelium are emerging.

View Article and Find Full Text PDF

Pancreatic cancer is a highly aggressive malignancy with a dismal prognosis, characterized by a complex tumor microenvironment that promotes immunosuppression and limits the efficacy of immune checkpoint blockade (ICB) therapy. Fibroblast activation protein (FAP) is overexpressed in the tumor stroma and represents a promising target for therapeutic intervention. Here, we developed a novel antibody-drug conjugate (ADC) targeting FAP, and investigated its anti-tumor activity and ability to enhance ICB efficacy in pancreatic cancer.

View Article and Find Full Text PDF